Similarly, a study in 2013 revealed statistically poorer disease-free survival (DFS) in patients with elevated CRP values, encompassing Ewing’s sarcoma and chondrosarcoma, without specifying cut-off values or entity distinctions [20]. The gene discussed is CRP; the disease is Ewing sarcoma.